JHS Svendgaard Laboratories share price
NSE: JHSFMCGHousehold & Personal Products
JHS Svendgaard Laboratories at a glance
JHS Svendgaard Laboratories (NSE: JHS) closed at ₹12.45 on 30 Sep 2026. With a market capitalisation of ₹109 Cr, it ranks 2613th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the FMCG sector; its industry is Household & Personal Products.
Its return on equity was 0.1% in FY25. Over the past year the share price has risen 14.1%. Its 52-week range is ₹6.26 (30 Mar 2026) to ₹13.90 (27 Oct 2025); the last close is 10.4% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹33 Cr (+29.9% year on year) and net profit −₹4 Cr, on a consolidated basis. Promoters held 33.85% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹109 CrRank 2613 on NSE
- Price to book
- 3.37×FY25
- EPS (TTM)
- −₹0.23to Q4 FY26
- ROE
- 0.1%FY25
- ROCE
- 0.1%FY25
- Debt to equity
- 0.07FY25
- Net profit margin
- 0.0%FY25
- Book value / share
- ₹17.66FY25
- 52-week high
- ₹13.9027 Oct 2025
- 52-week low
- ₹6.2630 Mar 2026
- 1-year return
- +14.1%
- RSI (14-day)
- 82.6
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | +20.41% | +47.9% | +54.5% | +62.8% | +14.1% |
JHS Svendgaard Laboratories quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹24 Cr | ₹20 Cr | ₹23 Cr | ₹25 Cr | ₹23 Cr | ₹22 Cr | ₹23 Cr | ₹33 Cr |
| Revenue YoY | +28.6% | +4.0% | +58.5% | +16.2% | −4.2% | +13.2% | +2.7% | +29.9% |
| Net profit | −₹1 Cr | −₹10 Cr | −₹2 Cr | −₹7 Cr | ₹1 Cr | −₹0 Cr | ₹1 Cr | −₹4 Cr |
| Net profit YoY | — | — | −18,500.0% | — | — | — | — | — |
| Net margin | −2.6% | −52.4% | −8.1% | −27.7% | 4.5% | −0.9% | 3.4% | −10.9% |
| EPS | −₹0.08 | −₹1.24 | −₹0.21 | −₹0.84 | ₹0.12 | −₹0.02 | ₹0.09 | −₹0.42 |
JHS Svendgaard Laboratories financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Operating profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS (₹) | ₹0.02 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.01 |
| Cash from operations | ₹1 Cr | −₹0 Cr | −₹1 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
JHS Svendgaard Laboratories shareholding pattern
| Holder | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 1 Feb 2026 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 34.56% | 34.56% | 34.56% | 33.85% | 33.85% | 33.85% |
| Foreign institutions | 1.59% | 1.57% | 1.57% | 3.60% | 3.60% | 3.14% |
| Non-institutions | 63.85% | 63.87% | 63.87% | 62.56% | 62.56% | 63.01% |
JHS Svendgaard Laboratories vs peers
The listed FMCG companies nearest to JHS Svendgaard Laboratories by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| VISHWARAJVishwaraj Sugar Industries | ₹5.08 | −1.36% | −36.9% | ₹111 Cr | — | — |
| JHSJHS Svendgaard Laboratories | ₹12.45 | +20.41% | +14.1% | ₹109 Cr | — | — |
| THRIVEThrive Future | — | — | — | ₹109 Cr | — | — |
| DHAMPUREDhampure Specia | — | — | — | ₹108 Cr | — | — |
| ABVLArunjyoti Bio | — | — | — | ₹107 Cr | — | — |
| MCFLMayank Cattle | — | — | — | ₹106 Cr | — | — |
| PURETROPPuretrop Fruits | — | — | — | ₹105 Cr | — | — |
Ask anything about JHS Svendgaard Laboratories
Pivot answers on the live chart with evidence you can check, and tests strategies against JHS's own history. Try: “Why has JHS moved over the last three months?” · “Backtest a 50-day moving-average crossover on JHS over five years” · “Compare JHS with VISHWARAJ on margins and valuation”
Frequently asked questions about JHS Svendgaard Laboratories
What is the share price of JHS Svendgaard Laboratories today?
JHS Svendgaard Laboratories (NSE: JHS) last closed at ₹12.45 on 30 Sep 2026. Its 52-week high is ₹13.90 and its 52-week low is ₹6.26.
What is the market cap of JHS Svendgaard Laboratories?
JHS Svendgaard Laboratories' market capitalisation is ₹109 Cr (₹109 Cr) at the 22 Oct 2026 close, ranking 2613th among the NSE companies Pivot tracks.
What is the ROE and ROCE of JHS Svendgaard Laboratories?
Return on equity was 0.1% in FY25 and return on capital employed was 0.1% in FY25 (standalone figures).
Is JHS Svendgaard Laboratories a debt-free company?
No. JHS Svendgaard Laboratories' debt-to-equity ratio was 0.07 in FY25, with total debt of ₹0 Cr.
What were JHS Svendgaard Laboratories' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), JHS Svendgaard Laboratories reported revenue of ₹33 Cr, +29.9% year on year, and net profit of −₹4 Cr.
How has JHS Svendgaard Laboratories stock performed over the last year?
JHS Svendgaard Laboratories' share price has risen 14.1% over the past year, +62.8% over three months and +54.5% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of JHS Svendgaard Laboratories?
As of 30 Jun 2026: promoters 33.85%, foreign institutions 3.14%, non-institutions 63.01%.
Who are JHS Svendgaard Laboratories' competitors?
The listed FMCG companies closest to JHS Svendgaard Laboratories by market cap are Vishwaraj Sugar Industries, Thrive Future, Dhampure Specia, Arunjyoti Bio, Mayank Cattle and Puretrop Fruits.
Is JHS Svendgaard Laboratories a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out JHS Svendgaard Laboratories' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on JHS against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 30 Sep 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all FMCG stocks · companies starting with J · all NSE stocks · this page as text